Moderna | MRNA - Interest Expense On Debt



Moderna reported $1000K in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
Acadia Pharmaceuticals 0 4.12M Sep/2024
Agios Pharmaceuticals 3.01M 10.05M Dec/2024
Alnylam Pharmaceuticals USD 40.25M 1.6M Jun/2025
Amgen USD 694M 29M Jun/2025
Arrowhead Research USD 24.38M 2.74M Jun/2025
Biogen USD 72.6M 12.6M Jun/2025
BioMarin Pharmaceutical USD 2.68M 184K Jun/2025
Celltrion KRW 17.04B 1.34B Mar/2025
Cspc Pharmaceutical 10.38M 934K Dec/2024
Dianthus Therapeutics 4.44M 263K Sep/2024
Divis Laboratories Ltd 30M 20M Jun/2025
Gilead Sciences USD 254M 6M Jun/2025
GlaxoSmithKline 184M 22M Jun/2025
Incyte USD 594K 66K Jun/2025
Ionis Pharmaceuticals USD 19M 0 Jun/2025
Kangmei Pharma CNY 1.67M 1.45M Mar/2025
Knight Therapeutics CAD 1.91M 369K Sep/2024
Laboratorios Farma 699K 666.2K Jun/2025
Moderna USD 1000K 0 Jun/2025
Qiagen NV USD 7.6M 311K Jun/2025
Regeneron Pharmaceuticals USD 3.6M 5.1M Jun/2025
Sarepta Therapeutics USD 5.23M 725K Jun/2025
Sartorius 41.4M 51.4M Jun/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Tilray USD 7.77M 2.08M Nov/2024
Ultragenyx Pharmaceutical 14.04M 1.48M Jun/2025
United Therapeutics USD 7.3M 1.2M Jun/2025
Vertex Pharmaceuticals USD 3.7M 900K Jun/2025
Zz Pientze Pharmaceu 46.05M 36.5M Jun/2025